Toe amputations with SGLT-2 inhibitors: data from randomized clinical trials

被引：0
|
作者：
Matteo Monami
Stefania Zannoni
Besmir Nreu
Edoardo Mannucci
机构：
[1] Careggi Teaching Hospital,Diabetology
[2] Careggi Teaching Hospital,Geriatric Medicine
来源：
Acta Diabetologica | 2017年 / 54卷
关键词：
Intervention study; Hypoglycemic agents; Diabetic ketoacidosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：411 / 413
页数：2
相关论文
共 50 条
  • [21] Erratum to: Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials
    Matteo Monami
    Ilaria Dicembrini
    Edoardo Mannucci
    Acta Diabetologica, 2017, 54 : 37 - 38
  • [22] Effect of SGLT-2 inhibitors on cardiovascular outcomes in heart failure patients: A meta-analysis of randomized controlled trials
    Lu, Yuan
    Li, Fei
    Fan, Yong
    Yang, Yu
    Chen, Minglong
    Xi, Jue
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 87 : 20 - 28
  • [23] SGLT-2 Inhibitors and Regenerative Cell Exhaustion
    Hess, David A.
    Terenzi, Daniella C.
    Verma, Subodh
    CELL METABOLISM, 2020, 31 (05) : 884 - 885
  • [24] Adverse effects and safety of SGLT-2 inhibitors
    Halimi, S.
    Verges, B.
    DIABETES & METABOLISM, 2014, 40 : S28 - S34
  • [25] Short and medium-term efficacy of sodium glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized clinical trials
    Monami, Matteo
    Liistro, Francesco
    Scatena, Alessia
    Nreu, Besmir
    Mannucci, Edoardo
    DIABETES OBESITY & METABOLISM, 2018, 20 (05): : 1213 - 1222
  • [26] Urinary tract infections with SGLT-2 inhibitors
    Reactions Weekly, 2019, 1749 (1) : 11 - 11
  • [27] SGLT-2 inhibitors for the prevention of recurrent nephrolithiasis
    Sakhaee, Khashayar
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 387
  • [28] SGLT-2 inhibitors: risk of diabetic ketoacidosis
    Reactions Weekly, 2020, 1815 (1) : 10 - 10
  • [29] SGLT-2 inhibitors and their potential in the treatment of diabetes
    Rosenwasser, Rebecca F.
    Sultan, Senan
    Sutton, David
    Choksi, Rushab
    Epstein, Benjamin J.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 453 - 467
  • [30] SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
    Inzucchi, Silvio E.
    Zinman, Bernard
    Wanner, Christoph
    Ferrari, Roberto
    Fitchett, David
    Hantel, Stefan
    Espadero, Rosa-Maria
    Woerle, Hans-Juergen
    Broedl, Uli C.
    Johansen, Odd Erik
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (02): : 90 - 100
12345